- 7024 malaria professionals are enjoying the free benefits of MalariaWorld today

Who's online
There are currently 5 users and 244 guests online.
Online users
- Inga
- Bart Knols
- Moon
- patrick sampao
- Kabogo
News Flash
Latest Jobs
Events 2010
Recent blog posts
- Job: Postdoctoral Fellow: Malaria transmission-blocking research (Entomologist/Malariologist)
- Job: ACT Consortium Policy Liaison Officer
- Harnessing Immunity Genes Against Plasmodium: The Series
- We thought we were down to 655.000 deaths in 2010, right?
- Job: Postdoctoral Fellow: Malaria resistance research
- Let the sun shine
- Postdoctoral Fellows: Malaria research
- Guest Editorial: Don't fake it!
- Loop mediated amplification question
- Criticism, Ideas and the Maya example
Malaria parasites contain a complete glutathione (GSH) redox system, and several enzymes of this system are considered potential targets for antimalarial drugs.
These data highlight the importance of rational vaccine design and support the advancement of adenovector delivery technology for a malaria vaccine.
The study demonstrates that genetic manipulation provides a platform for the designed, complete attenuation of malaria parasite blood stages and suggests testing the safety and efficacy of P. falciparum NT1 knockout strains in humans.